These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2463035)

  • 1. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement.
    Eriksson BI; Zachrisson BE; Teger-Nilsson AC; Risberg B
    Br J Surg; 1988 Nov; 75(11):1053-7. PubMed ID: 2463035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group.
    Br J Surg; 1988 Nov; 75(11):1058-63. PubMed ID: 2905187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of a low molecular weight heparin (Logiparin) versus dextran as prophylaxis against thrombosis after total hip replacement.
    Mätzsch T; Bergqvist D; Fredin H; Hedner U
    Acta Chir Scand Suppl; 1988; 543():80-4. PubMed ID: 2461017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
    Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of deep vein thrombosis in patients with hip fractures: low molecular weight heparin versus dextran.
    Oertli D; Hess P; Durig M; Laffer U; Fridrich R; Jaeger K; Kaufmann R; Harder F
    World J Surg; 1992; 16(5):980-4; discussion 984-5. PubMed ID: 1281362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study Group.
    Arch Intern Med; 1991 Aug; 151(8):1621-4. PubMed ID: 1714709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery.
    Dechavanne M; Ville D; Berruyer M; Trepo F; Dalery F; Clermont N; Lerat JL; Moyen B; Fischer LP; Kher A
    Haemostasis; 1989; 19(1):5-12. PubMed ID: 2537787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparin compared with dextran as prophylaxis against thrombosis after total hip replacement.
    Mätzsch T; Bergqvist D; Fredin H; Hedner U
    Acta Chir Scand; 1990; 156(6-7):445-50. PubMed ID: 1695053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weill D; Butel J
    Thromb Haemost; 1988 Dec; 60(3):407-10. PubMed ID: 2853459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does dihydroergotamine potentiate the thromboprophylactic effect of dextran 70? A controlled prospective study in general and hip surgery.
    Bergqvist D; Lindblad B; Ljungström KG; Persson NH; Hallböök T
    Br J Surg; 1984 Jul; 71(7):516-21. PubMed ID: 6203596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
    Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
    J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
    Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
    BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.
    Sasahara AA; Koppenhagen K; Häring R; Welzel D; Wolf H
    Br J Surg; 1986 Sep; 73(9):697-700. PubMed ID: 3530367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery.
    Nurmohamed MT; Verhaeghe R; Haas S; Iriarte JA; Vogel G; van Rij AM; Prentice CR; ten Cate JW
    Am J Surg; 1995 Jun; 169(6):567-71. PubMed ID: 7771617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
    Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
    Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture.
    Monreal M; Lafoz E; Navarro A; Granero X; Caja V; Caceres E; Salvador R; Ruiz J
    J Trauma; 1989 Jun; 29(6):873-5. PubMed ID: 2544742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery.
    Lassen MR; Borris LC; Christiansen HM; Møller-Larsen F; Knudsen VE; Boris P; Nehen AM; de Carvalho A; Jurik AG; Nielsen BW
    Br J Surg; 1988 Jul; 75(7):686-9. PubMed ID: 2843255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The case for more active prevention of deep-vein thrombosis after major surgery (author's transl)].
    Hubens A; Peeters R
    Acta Chir Belg; 1976 Jul; 75(4):402-15. PubMed ID: 797205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
    Tapson VF; Hull RD
    Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.